Company Profile
High Quality & Competitive Price Kinase Inhibitors Reagnets Biochempartner is a enterprise specializing in the various inhibitors synthesis.We produce most of our products ourself,so we have huge advantages for bulk quantity.After 3 years accumulation,we have many inhibitors in stock,and our product include:PI3K inhibitors;AKT inhibitors;mTOR inhibitors;c-MET inhibitors;HDAC Inhibitors;Bcl-2 protein Family Inhibitors;Aurora Kinase Inhibitors;ALK Inhibitor;PARP inhibitor;AUR inhibitors;Agonist;Antagonist;etc. Our advantage: 1.bulk quantity inhibitors 2.Chiral HPLC preparation
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
3,4-Diaminofurazan |
FURAZAN-3,4-DIAMINE;Furazandiamine;3,4-Diamino-1,2,5-oxadiazole;3,4-DIAMINOFURAZAN;3,4-DIAMINOFURAZANE;4-AMINO-1,2,5-OXADIAZOL-3-YLAMINE;AKOS BB-9341;TIMTEC-BB SBB000032 |
17220-38-1 | Inquiry | |
3-Acetyl-2-chloropyridine |
1-(2-chloro-3-pyridinyl)-1-ethanone;2-chloro-3-acetylpyridine;1-(2-chloro-3-pyridinyl)ethanone;1-(2-chloro-3-pyridinyl)ethanone(SALTDATA: FREE);1-(2-chloropyridin-3-yl)ethan-1-one;1-(2-Chloropyridin-3-yl)ethan-1-one, 2-Chloro-3-ethanoylpyridine;3-Acetyl-2-chloropyridine 95%;Ethanone, 1-(2-chloro-3-pyridinyl)- |
55676-21-6 | Inquiry | |
3-Aminobenzamide |
Benzamide,3-amino-;Benzamide,m-amino-;3-Aminobenzamide;m-Aminobenzamide;SR 4294;[3-(Aminocarbonyl)phenyl]amine;NSC 36962;3-Carboxamidoaniline;WD 97-000835;3-(Aminocarbonyl)aniline;3-Carbamoylaniline;INO 1001;624747-02-0 |
3544-24-9 | Inquiry | |
4-BroMo-7-Azaindol |
1H-PYRROLO[2,3-B]PYRIDINE, 4-BROMO-;4-BROMO-7-AZAINDOLE;4-BROMO-1H-PYRROLO[2,3-B]PYRIDINE;4-broMo-1H-pyrrolo[2;4-BroMo-7-Azaindol;4-Bromo-1H-pyrrolo-[2,3]pyridine;348640-06-2 |
348640-06-2 | Inquiry | |
6-[2-(tert-Butoxycarbonyl)hydrazinyl]nicotinic acid |
3-Pyridinecarboxylic acid,6-[1-[(1,1-dimethylethoxy)carbonyl]hydrazinyl]-;3-Pyridinecarboxylic acid,6-[2-[(1,1-dimethylethoxy)carbonyl]hydrazino]-;6-[1-[(1,1-Dimethylethoxy)carbonyl]hydrazinyl]-3-pyridinecarboxylic acid;6-[2-(tert-Butoxycarbonyl)hydrazinyl]nicotinic acid;6-Boc-Hynic;2567571-34-8 |
133081-25-1 | Inquiry | |
Abiraterone(CB-7598) |
Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-,(3β)-;(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol;CB 7598;Abiraterone;17-(3-Pyridinyl)-androsta-5,16-dien-3β-ol |
154229-19-3 | Inquiry | |
ABT-263(Navitoclax) |
Benzamide,4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]-;4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide;ABT 263;Navitoclax;A 855071.0;1000696-69-4 |
923564-51-6 | Inquiry | |
ADL-5859 |
ADL-5859;N,N-Diethyl-4-(5-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-4-yl)benzamide hydrochloride;ADL5859 HCl;ADL5859 hydrochloride;Benzamide, N,N-diethyl-4-(5-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-4-yl)-, hydrochloride (1:1);N,N-Diethyl-4-(5-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-4-yl)benzamide hydrochlorideADL-5859 |
850173-95-4 | Inquiry | |
Adriamycin(Doxorubicin) |
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,hydrochloride (1:1),(8S,10S)-;Adriamycin,hydrochloride;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S-cis)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S,10S)-;Doxorubicin hydrochloride;Adriamycin;Adriacin;Adriblastina RD;Adriblastina;Adriblastin;ADR;DOX HCl;FI 6804;ADM hydrochloride;Hydroxydaunorubicin hydrochloride;FI 106;Adriablastina CS;Lipo-Dox;Adrosal;Ameisu hydrochloride;Myocet liposomal;Doxolipad;Caelyx pegylated liposomal;Doxorubicin-TEVA;Doxorubicin-LANS |
25316-40-9 | Inquiry | |
AG-014699 |
AG-014699;PF-01367338;AG14699;8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one phosphate;Rucaparib (AG-014699 , PF-01367338);Rucaparib phosphate;AG-014699 (Rucaparib);6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(MethylaMino)Methyl]phenyl]-, phosphate (1:1) |
459868-92-9 | Inquiry | |
Allyl cyclohexyloxyacetate |
Acetic acid,2-(cyclohexyloxy)-,2-propen-1-yl ester;Acetic acid,(cyclohexyloxy)-,2-propenyl ester;Isoananat;Cyclogalbanate;Cyclogalbaniff;Allyl 2-(cyclohexyloxy)acetate;Prop-2-enyl 2-cyclohexyloxyacetate;Allyl (cyclohexyloxy)acetate;380366-79-0 |
68901-15-5 | Inquiry | |
BCP0027/BEZ235/NVP-BEZ235/BE-Z235/ |
Benzeneacetonitrile,4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-α,α-dimethyl-;4-[2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-α,α-dimethylbenzeneacetonitrile;2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile;NVP-BEZ 235;BEZ 235;Dactolisib;NVP-BEZ 235NX;NVPBE 235;BEZ 23;RTB 101;2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-1H,2H,3H-imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile;2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile;1146702-52-4 |
915019-65-7 | Inquiry | |
GDC-0449(Vismodegib) |
Benzamide,2-chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)-;2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide;GDC 0449;Vismodegib;Erivedge |
879085-55-9 | Inquiry | |
GDC-0879 |
GDC-0879;(E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime,GDC-0879;2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime;1H-Inden-1-one, 2,3-dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-, oxiMe;GDC 0849;(E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime;2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-pyridin-4-yl-1H-pyrazol-1-yl}ethanol;(Z)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime |
905281-76-7 | Inquiry | |
Gefitinib/ZD-1839,Iressa |
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;Iressa;Gefitinib;4-(3′-Chloro-4′-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;(3-Chloro-4-fluorophenyl)[7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl]amine;4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline;ZD1839;Gefonib;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
184475-35-2 | Inquiry | |
Gemcitabine Hydrochloride/Gemzar |
Cytidine,2′-deoxy-2′,2′-difluoro-,hydrochloride (1:1);Cytidine,2′-deoxy-2′,2′-difluoro-,monohydrochloride;LY 188011 hydrochloride;Gemcitabine hydrochloride;Gemzar;Gemsar;Gemcitera;GEMORAL;2′-Deoxy-2′,2′-difluorocytidine monohydrochloride |
122111-03-9 | Inquiry | |
GSK-461364 |
2-Thiophenecarboxamide,5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-;5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide;5-[6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl]-3-[[(1R)-1-[2-(trifluoromethyl)phenyl]ethyl]oxy]thiophene-2-carboxamide;GSK 461364;GSK 461364A;1000873-97-1 |
929095-18-1 | Inquiry | |
GSK-690693 |
3-Butyn-2-ol,4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-;4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol;GSK 690693;1000873-82-4 |
937174-76-0 | Inquiry | |
GSK1904529A |
GSK1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;GSK 4529;N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A;GSK1904529A, >=98%;IGF-IR, IGF-IIR inhibitor |
1089283-49-7 | Inquiry | |
Isocyclocitral |
Isocyclocitral |
1335-66-6 | Inquiry |
CONTACT INFORMATION
Sign In for Details